Putnam Investments’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-82,549
Closed -$14.2M 1223
2021
Q3
$14.2M Sell
82,549
-143,456
-63% -$24.7M 0.02% 290
2021
Q2
$28.4M Sell
226,005
-23,700
-9% -$2.97M 0.04% 212
2021
Q1
$33.9M Sell
249,705
-34,770
-12% -$4.72M 0.06% 203
2020
Q4
$36.4M Sell
284,475
-418
-0.1% -$53.5K 0.06% 186
2020
Q3
$32.1M Buy
284,893
+40,000
+16% +$4.5M 0.06% 191
2020
Q2
$23.3M Buy
244,893
+82,146
+50% +$7.83M 0.05% 216
2020
Q1
$14.6M Buy
162,747
+70,172
+76% +$6.31M 0.04% 258
2019
Q4
$4.91M Buy
92,575
+22,471
+32% +$1.19M 0.01% 509
2019
Q3
$2.77M Buy
70,104
+157
+0.2% +$6.2K 0.01% 655
2019
Q2
$2.87M Hold
69,947
0.01% 663
2019
Q1
$3.26M Buy
69,947
+67
+0.1% +$3.12K 0.01% 615
2018
Q4
$3.04M Buy
69,880
+4,896
+8% +$213K 0.01% 563
2018
Q3
$3.72M Buy
64,984
+39,080
+151% +$2.24M 0.01% 647
2018
Q2
$1.26M Sell
25,904
-2,684
-9% -$130K ﹤0.01% 820
2018
Q1
$1.12M Buy
28,588
+192
+0.7% +$7.51K ﹤0.01% 843
2017
Q4
$1.21M Sell
28,396
-14,232
-33% -$604K ﹤0.01% 867
2017
Q3
$1.59M Buy
42,628
+12,614
+42% +$470K ﹤0.01% 828
2017
Q2
$912K Sell
30,014
-106,786
-78% -$3.24M ﹤0.01% 912
2017
Q1
$3.62M Sell
136,800
-1,505
-1% -$39.8K 0.01% 718
2016
Q4
$3.53M Sell
138,305
-748
-0.5% -$19.1K 0.01% 702
2016
Q3
$5.03M Buy
139,053
+14,053
+11% +$509K 0.01% 571
2016
Q2
$4.25M Hold
125,000
0.01% 701
2016
Q1
$3.3M Hold
125,000
0.01% 803
2015
Q4
$6.1M Sell
125,000
-472
-0.4% -$23K 0.01% 595
2015
Q3
$3.12M Hold
125,472
0.01% 845
2015
Q2
$3.97M Buy
+125,472
New +$3.97M 0.01% 823